Intestinal ultrasound in inflammatory bowel disease

Research output: Contribution to journalReviewResearchpeer-review

Standard

Intestinal ultrasound in inflammatory bowel disease. / Bjerrum, Jacob Wium; Ilvemark, Johan; Seidelin, Jakob Benedict; Wilkens, Rune.

In: Ugeskrift for Laeger, Vol. 186, No. 6, 05.02.2024.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Bjerrum, JW, Ilvemark, J, Seidelin, JB & Wilkens, R 2024, 'Intestinal ultrasound in inflammatory bowel disease', Ugeskrift for Laeger, vol. 186, no. 6. https://doi.org/10.61409/V7230479

APA

Bjerrum, J. W., Ilvemark, J., Seidelin, J. B., & Wilkens, R. (2024). Intestinal ultrasound in inflammatory bowel disease. Ugeskrift for Laeger, 186(6). https://doi.org/10.61409/V7230479

Vancouver

Bjerrum JW, Ilvemark J, Seidelin JB, Wilkens R. Intestinal ultrasound in inflammatory bowel disease. Ugeskrift for Laeger. 2024 Feb 5;186(6). https://doi.org/10.61409/V7230479

Author

Bjerrum, Jacob Wium ; Ilvemark, Johan ; Seidelin, Jakob Benedict ; Wilkens, Rune. / Intestinal ultrasound in inflammatory bowel disease. In: Ugeskrift for Laeger. 2024 ; Vol. 186, No. 6.

Bibtex

@article{29f70503d035484aa2515b3456d7680e,
title = "Intestinal ultrasound in inflammatory bowel disease",
abstract = "Intestinal ultrasound (IUS) is non-invasive, fast, cheap, and well-tolerated and requires no preparation and is thus applicable as a point-of-care monitoring tool of inflammatory bowel disease (IBD). Evidence suggests that IUS is comparable to other standard monitoring modalities, i.e., endoscopy, MRI, calprotectin, and C-reactive protein and might be more accurate in predicting response to treatment at an early stage consequently allowing for timely optimised treatment. This review finds that integrating IUS as the standard of care in every IBD outpatient clinic and as the primary outcome in future medical trials seems inevitable.",
keywords = "Humans, Intestines/diagnostic imaging, Inflammatory Bowel Diseases/diagnostic imaging, C-Reactive Protein, Endoscopy, Gastrointestinal, Ultrasonography",
author = "Bjerrum, {Jacob Wium} and Johan Ilvemark and Seidelin, {Jakob Benedict} and Rune Wilkens",
note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",
year = "2024",
month = feb,
day = "5",
doi = "10.61409/V7230479",
language = "Dansk",
volume = "186",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "6",

}

RIS

TY - JOUR

T1 - Intestinal ultrasound in inflammatory bowel disease

AU - Bjerrum, Jacob Wium

AU - Ilvemark, Johan

AU - Seidelin, Jakob Benedict

AU - Wilkens, Rune

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/2/5

Y1 - 2024/2/5

N2 - Intestinal ultrasound (IUS) is non-invasive, fast, cheap, and well-tolerated and requires no preparation and is thus applicable as a point-of-care monitoring tool of inflammatory bowel disease (IBD). Evidence suggests that IUS is comparable to other standard monitoring modalities, i.e., endoscopy, MRI, calprotectin, and C-reactive protein and might be more accurate in predicting response to treatment at an early stage consequently allowing for timely optimised treatment. This review finds that integrating IUS as the standard of care in every IBD outpatient clinic and as the primary outcome in future medical trials seems inevitable.

AB - Intestinal ultrasound (IUS) is non-invasive, fast, cheap, and well-tolerated and requires no preparation and is thus applicable as a point-of-care monitoring tool of inflammatory bowel disease (IBD). Evidence suggests that IUS is comparable to other standard monitoring modalities, i.e., endoscopy, MRI, calprotectin, and C-reactive protein and might be more accurate in predicting response to treatment at an early stage consequently allowing for timely optimised treatment. This review finds that integrating IUS as the standard of care in every IBD outpatient clinic and as the primary outcome in future medical trials seems inevitable.

KW - Humans

KW - Intestines/diagnostic imaging

KW - Inflammatory Bowel Diseases/diagnostic imaging

KW - C-Reactive Protein

KW - Endoscopy, Gastrointestinal

KW - Ultrasonography

U2 - 10.61409/V7230479

DO - 10.61409/V7230479

M3 - Review

C2 - 38327204

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 6

ER -

ID: 387035114